News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diagnostic Firm diaDexus Awaits Possible Boom From GlaxoSmithKline (GSK) Trials


10/24/2013 8:21:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medical researchers often find tantalizing hints about the causes of disease when they spot biomolecules that seem to be closely associated with the onset of an illness—like the amyloid plaques seen in the brains of people with Alzheimer’s disease. Pharmaceutical companies often run with those hints, creating experimental drugs targeted at those suspect biomolecules. But are the suspect disease markers actually causing the illness, or are they just incidental symptoms or byproducts of it? Will a drug targeting a disease marker do anything to combat the disease?

Hey, check out all the engineering jobs. Post your resume today!

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES